Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Influenza
Pneumococcal disease
2022
2005
Europe
Clear all
Type of publications
NITAG documentation
(35)
Systematic reviews (SYSVAC)
(10)
Topics
Available to download in languages
Regions
Europe
(45)
Africa
(24)
Americas
(47)
Eastern Mediterranean
(3)
South-East Asia
(2)
Western Pacific
(19)
Countries
Belgium
(9)
France
(9)
Germany
(2)
Ireland
(4)
Italy
(2)
Luxembourg
(1)
Netherlands
(2)
Spain
(3)
Ukraine
(1)
United Kingdom
(7)
Diseases
COVID-19
(34)
Influenza
(7)
Pneumococcal disease
(4)
Haemophilus influenzae type B
(1)
Herpes zoster
(3)
Human papillomavirus (HPV)
(4)
Meningococcal disease
(1)
Mpox // Monkeypox
(8)
Pertussis
(1)
Rabies
(1)
Rotavirus
(2)
Varicella
(2)
Vaccine topics
Acceptance
(5)
Administration
(1)
Coverage
(5)
Economic aspects
(1)
Ethical issues
(4)
Target population
Adolescents
(1)
Adults
(1)
All age groups
(6)
Children
(5)
Healthcare workers
(4)
Newborn
(4)
Older adults
(1)
Parents/caregivers
(2)
Pregnant women
(1)
Risk group
(1)
Travellers
(1)
Publication date
2022
(42)
2005
(3)
2024
(1)
2023
(22)
2021
(79)
2020
(22)
2019
(12)
2018
(9)
2017
(10)
2016
(6)
2015
(9)
2014
(8)
2013
(6)
2012
(2)
2011
(8)
2010
(18)
2009
(7)
2007
(3)
2006
(2)
45 results found
2022
Recommendations from the Higher Council for Infectious Diseases for vaccination against pneumococcus for populations at risk adults (18 years and over) or aged 65 and over
2022
Vaccination recommendations against flu in children aged 6 to 59 months
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: Place of the VLA2001 vaccine
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: Place of the VidPrevtyn Beta vaccine
2022
∙
Haute Autorité de Santé
Booster vaccine strategy against Covid-19
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: Place of the Nuvaxovid vaccine in the booster strategy
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: role of the bivalent Spikevax Original / Omicron BA.4/BA.5 vaccine (mRNA-1273.222)
2022
Vaccination recommendations against flu in children aged 6 to 59 months
2022
∙
JCVI
JCVI Advice on influenza vaccines for 2023/24
2022
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against COVID-19 with mRNA vaccines for children from 6 months of age in Belgium
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register